您的购物车当前为空
别名 玛维泽利单抗, MK-4280, MK4280
Favezelimab (MK-4280) 是一种人源化单克隆抗体,靶向 LAG-3,通过抑制 LAG-3 与其配体 MHC II 的分子相互作用,恢复 T 细胞功能,Favezelimab 尤其用于与 PD-L1 抑制剂 Pembrolizumab (HY-P9902) 联合应用的协同作用的研究。
Favezelimab (MK-4280) 是一种人源化单克隆抗体,靶向 LAG-3,通过抑制 LAG-3 与其配体 MHC II 的分子相互作用,恢复 T 细胞功能,Favezelimab 尤其用于与 PD-L1 抑制剂 Pembrolizumab (HY-P9902) 联合应用的协同作用的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,650 | In Stock | |
| 5 mg | ¥ 6,150 | In Stock | |
| 10 mg | ¥ 8,280 | In Stock | |
| 25 mg | ¥ 12,300 | In Stock |
Favezelimab 相关产品
| 产品描述 | Favezelimab (MK-4280), a humanized monoclonal antibody directed against LAG-3, inhibits the molecular interaction between LAG-3 and its ligand MHC class II, thereby restoring T-cell function. Favezelimab (MK-4280) has been evaluated as a candidate for colorectal cancer (CRC) research, particularly in studies that investigate synergistic effects in combination with the PD-L1 inhibitor Pembrolizumab (HY-P9902). |
| 别名 | 玛维泽利单抗, MK-4280, MK4280 |
| CAS No. | 2231068-83-8 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
评论内容